Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target upped by equities research analysts at Royal Bank of Canada from $83.00 to $84.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target indicates a […]
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $88 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target lowered by investment analysts at Piper Sandler from $105.00 to $100.00 in a research report issued on Monday, FlyOnTheWall reports. Piper Sandler’s target price would indicate a potential upside of 26.34% from the stock’s previous close. GILD has been the topic of several other […]
Cantor Fitzgerald Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $80 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective lowered by Barclays from $84.00 to $81.00 in a research note published on Tuesday, FlyOnTheWall reports. A number of other research firms have also commented on GILD. StockNews.com started coverage on Gilead Sciences in a report on Thursday, May 18th. They issued a strong-buy rating […]